Real World Evidence Solutions Market
Real World Evidence Solutions Market Size and Growth
The Real World Evidence Solutions market is poised for significant growth, driven by increasing demand for data-driven insights in healthcare decisionmaking. The market size is projected to reach approximately $2 billion by 2025, reflecting an annual growth rate of over 15%, fueled by advancements in technology and regulatory support for real-world studies.
Companies Covered
(Covid 19 Impact Covered)
◍ Iqvia
◍ IBM
◍ Pharmaceutical Product Development
◍ Parexel
◍ United Health Group
◍ Perkinelmer
◍ Icon
◍ Oracle
◍ Cognizant
◍ Syneos Health
◍ Anthem
◍ Clinigen
◍ SAS Institute
The Real World Evidence Solutions Market features key players like IQVIA, IBM, Parexel, and ICON, utilizing RWE for drug development, regulatory compliance, and market access. Their analytics, data integration, and insights foster innovation and inform decisions, driving market growth. Notable revenues include:
- IQVIA: $13.4 billion
- IBM: $60.5 billion
- Parexel: $2.5 billion
Market Segmentation
By Application
◍ Pharmaceutical and Medical Device Companies ◍ Healthcare Payers
◍ Healthcare Providers
◍ Others
By Product
◍ Clinical Setting Data ◍ Claims Data ◍ Pharmacy Data ◍ Patient Powered Data
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
